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Introduction
In the mid of 19th century, it was supposed that malaria 
would be eradicated but now the disease is reached to an 
epidemic problem in the tropical regions in Africa and 
south of Asia. It is due to the several factors including in-
creasing the drug resistance of malarial parasites, and lim-
itation of use of insecticides because of toxicological prob-
lems and consequent failure in controlling anopheline 
mosquitoes. Malaria is caused by Plasmodium falciparum, 
P. vivax, P. malariae or P. ovale. Among them P. falciparum 
is reported to have more morbidity because of resistance 
of plasmodiums to chloroquine or other drugs. P. vivax is 
usually sensitive to treatment and P. malariae and P. ovale 
are uncommon (1). Current anti malarial drugs include 
quinine an alkaloid extracted from the bark of cinchona 
tree which is frequently used in the prevention and treat-
ment of malaria. Quinimax, quinidine and mefloquine are 
other alkaloids related to quinine in the treatment or pre-
Implication for health policy/practice/research/medical education:
Saffron and its fractions are effective in reducing the parasitemia in mice. The combination of ethyl acetate fraction with chloroquine 
has synergistic effect on the chloroquine–sensitive strain of parasite. Hence, the combination therapy might be useful in the 
treatment of malaria.
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Introduction: In malaria treatment protocols, treatment failure or drug resistance of synthesized 
drugs like alkaloids related to quinine, and aminoquinolines are the main problems now. 
Therefore, discovering efficient drugs or combination therapy of blood schizonticidal drugs with 
different mechanisms or different targets in the parasite is a crucial effort to solve this problem. 
In this study, the effectiveness of Crocus sativus Stigma (saffron) individually and in combination 
with chloroquine, was considered against chloroquine–sensitive strain of Plasmodium berghei.
Methods: At the first stage, using 4 day suppressive Peter’s test in mice, ED50 and survival times of 
saffron methanol extract, and its aqueous and ethyl acetate fractions and chloroquine on P. berghei 
were calculated. Then, based on the toxicity and survival time results, combination therapy was 
conducted with the best saffron fraction and chloroquine against the parasite. 
Results: The saffron extract, aqueous and ethyl acetate fractions resulted in suppression of 
parasitemia with ED50 values of 587.0 ± 78.7, 323.7 ± 37.2, and 508.7 ± 35.6 mg/kg, respectively. 
Combination of ethyl acetate fraction with chloroquine, potentiated the antimalarial property and 
the survived percent of the treated mice on days 7, 14, and 28 significantly more than chloroquine 
or ethyl acetate fraction alone.
Conclusion: Saffron and its fractions individually can be effective in reducing the parasitemia in 
mice. The outcome of combination of ethyl acetate fraction with chloroquine on the mice showed 
synergistic effect on the chloroquine–sensitive strain of parasite. 
A R T I C L E  I N F O
Keywords:
Crocus sativus
Saffron
Plasmodium berghei
Combination therapy
Chlor
Article History:
Received: 7 May 2015
Accepted: 5 September 2015
Article Type:
Original Article
A B S T R A C T
Effective of Saffron on Plasmodium berghei 
Journal of HerbMed Pharmacology, Volume 4, Number 4, October 2015http://www.herbmedpharmacol.com 111
vention of malaria (2). Chloroquine, and amodiaquine are 
another widely used antimalarial drugs with 4-aminoqui-
nolone structure but, drug-resistant was rapidly decreased 
their effectiveness (2,3). Primaquine is 8-aminoquinolone 
for treatment of different types of malaria infection with 
blocking the oxidative metabolism in plasmodia (2). Ar-
temisinin and artesunate are sesquiterpene lactones with 
a chemically rare peroxide bridge linkage effective against 
multidrug resistant P. falciparum (4). 
Despite the administration of drugs, increasing the risks 
of treatment failure because of developing resistance is the 
main problem, now. Therefore, discovering new and ef-
ficient drugs or combination therapy of 2 or more blood 
schizonticidal drugs with different mechanisms and dif-
ferent targets in the parasite is a crucial effort to solve 
this problem (5). Saffron is a spice derived from the styles 
and stigmas of the flower of Crocus sativus L., commonly 
known as the “za’ferân” in Persian. It is grown from Spain 
in the west to India in the east but southeastern provinces 
in Iran including Khorasan region produce approximately 
most of the world production (6). The stigmas are mostly 
used as food spice and colorant. There are also some re-
ports on the effectiveness of saffron for the treatment of 
malaria (Tab-e- se-yek in Persian) in the Islamic medical 
manuscripts (7). Saffron contains carotenoids, including 
zeaxanthin, lycopene, and α- and β-carotenes (8). Crocin 
is a carotenoid that may comprise up to 10% of dried saf-
fron. Picrocrocin and safranal has insecticidal and pes-
ticidal properties and may comprise to more than 4% of 
saffron’s mass (8). In a recent research crocin derived from 
saffron and safranal semi-synthetic derivatives showed in 
vitro anti-malarial properties (9). Therefore, saffron was 
selected alone or in combination with chloroquine in this 
study for evaluation of its anti-malarial properties in P. 
berghei infected mice as an experimental in vivo model.
Materials and Methods
Plant material
Saffron, the dried stigmas of the Crocus sativus flowers, 
was obtained from Global international saffron company, 
Torbat-e-Heydarieh, Khorasan, Iran and identified at the 
Pharmacognosy Department, School of Pharmacy, Isfah-
an University of Medical Sciences. The plant material was 
milled into a fine powder (100 g) and then macerated with 
ethanol (600 mL × 3), at room temperature for three days. 
The extract was evaporated in a vacuum system at 40ºC 
(Rotary evaporator, Heidolph Co. Germany) to a dark red 
residue which was subjected to liquid/liquid partitioning 
between water and ethyl acetate. Aqueous and ethyl ace-
tate fractions were evaporated to remove solvent and kept 
in refrigerator in -20°C before use. 
Animals
Male albino sourian mice, weighing between 23 to 27 g 
supplied from Pasteur Institute of Iran, were randomly 
assigned to treatment and control groups with 7 mice in 
each group. The mice were kept at room temperature in 
accordance with the internationally accepted principles 
for laboratory animal use and care, and were given ad libi-
tum access to food and water. 
Parasites
Chloroquine-sensitive P. berghei NICD strain from Haff-
kine Institute of India was used in the study. Two weeks 
previous to the tests the parasites (stored in nitrogen liq-
uid) were rethawed and maintained by blood passage in 
saurian mice, intra-peritoneal. The donor mice with 10% 
parasitaemia were then sacrificed and blood was collected 
and diluted with normal saline into heparinized falcon 
tubes (5 × 106/mL infected erythrocytes). Treatment mice 
were inoculated with 106 parasitized erythrocytes in 0.2 
ml dilution, intra peritoneal.
Antimalarial in vivo assay
The anti-malarial study requires in vitro methods or in 
vivo test models. The most common in vivo test utilize 
P. berghei in a 4 day suppressive test in mice (Peter’s test). 
Different dose levels (350, 700, and 1000 mg/kg) of saf-
fron total extract, aqueous and ethyl acetate fractions and 
chloroquine (20 mg/kg) were administered to groups of 5 
mice in each group in addition to 5 mice uninfected mice 
as negative control and 5 infected but treated with physi-
ological saline + 2% tween 80 as placebo were prepared. 
Two hours after parasite inoculations in day zero, plant 
extracts and chloroquine were injected into the infected 
mice and repeated once daily for 4 consecutive days. On 
fifth day a thin blood smear of the tail blood of each of 
the mice was prepared on microscope slides, fixed with 
absolute methanol, and stained with 10% Giemsa stain 
in distilled water. Percentage of parasitaemia suppression 
was determined by counting parasites against 200 eryth-
rocytes on days 5, 7, 14 and 28 for Peter’s test using the 
following formula (10).
Mean parasitemia of placebo – mean parasitemia of treated group
Mean parasitemi
%supp
a of 
re
pl
ssion=
acebo
If any animals died before the end of the fourth day, the 
death was considered for the extract toxicity (1). Combi-
nation therapy was then conducted with three treatment 
groups 1, 2 and 3 treated with best fraction of saffron ex-
tract, chloroquine (20 mg/kg) and a combination of these 
two, in addition to negative control (nor infected , nor 
receiving any of the agents) and placebo. Interaction was 
evaluated as additive, synergism or antagonism, respec-
tively. The treated mice were followed up in both screen-
ing and combination method for 28 days after injection 
(on days 5, 7, 14, and 28), and survival time of the mice 
was recorded in each test group (10-12).
Ethics
All the animals were handled in accordance with the in-
ternationally accepted principles and guides for the care 
and use of laboratory animals in 2010 (11), and the Ethics 
Committee of Isfahan University of Medical Sciences.
Statistical analysis 
The ED50 value (drug concentration causing 50% of maxi-
mum suppression) of the samples were calculated based 
on semi-log graphs. Values are given as mean ± standard 
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error of mean (SEM). Statistical analysis was performed 
using Student’s t test and/or one-way analysis of variance 
(ANOVA) as appropriate and Bonferroni post hoc test 
to identify the differences between treated groups and 
control.
Results
General mean ± SD for all study samples for age and weight 
on day zero was 4 weeks old and 27.1 ± 3.4 g, respectively. 
There were no statistically significant differences between 
groups in terms of basic characteristics. 
The data were analyzed with 2 factors related to the para-
sitemia suppression and survival time. 
In between group analysis, there was a significant differ-
ence between the mean of placebo and total extract and 
ethyl acetate fraction at concentrations of 700 and 1050 
mg/kg on day 4 (24 hours after the last dose), P < 0.001. 
Aqueous extract in all the concentrations (350, and 1050 
mg/kg) showed parasitemia suppression significantly 
more than placebo (P < 0.001; Figure 1).
The saffron extract, aqueous and ethyl acetate fractions 
resulted in suppression of parasitemia with ED50 values of 
587.0 ± 78.7, 323.7 ± 37.2, and 508.7 ± 35.6 mg/kg, respec-
tively. It means that aqueous fraction with lower ED50 is 
more effective in decreasing the parasitemia than ethyl 
acetate and total extract. However, none of the observed 
activities of the extracts and fractions was comparable to 
that of chloroquine (P < 0.05).
The mice were followed up for 28 days and ANOVA re-
sults showed that mean survival time of the treated mice 
with chloroquine 20 mg/kg (23.6 days) and ethyl acetate 
700 mg/kg (17.8 days) were significantly (P < 0.05) more 
than placebo (10.8 days) while total extract and aqueous 
fraction treated groups did not show significant differ-
ences with placebo. It means that ethyl acetate fraction 
(700 mg/kg) has longer survival time than other saffron 
derived treated groups. 
Considering the toxicity of total extract, ethyl acetate and 
aqueous fraction in various concentrations, aqueous frac-
tion (1050 mg/kg) showed more toxicity with two mice 
died and ethyl acetate fraction (700 mg/kg) exhibited less 
toxicity with no death in mice under test before the end of 
the fourth day.
Combination therapy was then conducted with three 
treatment groups 1, 2 and 3 treated with ethyl acetate frac-
tion of saffron extract (700 mg/kg), chloroquine (20 mg/
kg) and a combination of these 2, in addition to negative 
control and placebo (Figure 2). 
There was a significant difference between the parasitemia 
suppression of ethyl acetate fraction, chloroquine and 
combination of these 2 with placebo on day 4 (P < 0.001) 
but there was no statistically significant difference between 
combination group and chloroquine alone (P > 0.05).
ANOVA results showed that survived percent of the 
treated mice with chloroquine + ethyl acetate fraction on 
days 7, 14, and 28 were significantly (P < 0.05) more than 
chloroquine or ethyl acetate fraction alone. It means that 
survival time interaction between ethyl acetate fraction 
and chloroquine against the P. berghei showed a synergism 
pattern (Table 1).
Discussion
The saffron total extract, aqueous and ethyl acetate frac-
tions significantly resulted in suppression of parasitemia 
in mice infected with P. berghei. However, their effective-
ness against P. berghei parasitemia was not comparable 
with chloroquine. Combination therapy of chloroquine 
(20 mg/kg) with saffron ethyl acetate fraction (700 mg/kg) 
significantly prolonged survival time against the P. berghei 
parasitemia in comparison with chloroquine or ethyl ac-
etate fraction alone. 
Investigation on the antimalarial effects of medicinal 
herbs alone or in combination with current antimalarial 
drugs opened a new field of research against plasmodium 
infections. 
Motevalli Haghi et al (12) examined the effectiveness of 
Peganum harmala on P. berghei. with considerable effect 
in 100 mg/kg dosage. Nahrevanian and colleagues report-
ed antimalarial activity of Artemisia khorassanica and Ar-
temisia sieberi against P. berghei in mice (13,14). Different 
parts of plants of the Simaroubaceae family are used tradi-
tionally in the treatment of malaria. These plants contain 
quassinoid alkaloids like simaroubolide compound that 
are responsible for this activity (15). Stem bark of Alstonia 
Figure 1. Parasitemia suppression (mean ± SEM) of infected 
mice treated with crude extract, ethyl acetate and aqueous 
fractions of saffron on day 4 (1 day after cessation of treatment) in 
Peter’s antimalarial test.
Figure 2. Parasitemia suppression (mean ± SEM) of infected 
mice treated with ethyl acetate fraction of saffron (700 mg/
kg), chloroquine (20 mg/kg),  ethyl acetate fraction (700 mg) + 
chloroquine (20 mg) and placebo on day 4 (1  day after cessation 
of treatment) in Peter’s antimalarial test.
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(Apocynaceae) exhibits antipyretic and antimalaria prop-
erties and has been used in the past for malarial treatment 
(16). The roots of Cryptolepis sanguinolenta from Ascle-
piadaceae family have been used in Africa as antimalar-
ial drug. Cryptolepine and isocryptolepine are identified 
from these plants as responsible indoloquinoline alkaloids 
for this effect (17). The barks of Cinchona species a rich 
source of quinine and other quinolidine alkaloids were 
used for treatment of malaria fever from times long ago 
(18). The African antimalarial medicinal plants genus An-
cistrocladus and Triphyophyllum peltatum contain naph-
thyl isoquiniline alkaloids like Yaoundamine and Habrop-
etaline alkaloids with considerable in vitro antimalarial 
activity with good selectivity indices (19,20). Stem bark 
of Pogonopus tubulosus a tree from South America used 
traditionally in Bolivia against malaria and contains tu-
bulosine indoline alkaloid with potent antimalarial activ-
ity in mice (21). Glycyrrhiza glabra a plant native to Iran 
contains licochalcone A and 18β-glycyrrhetinic acid with 
promised in vitro activities against P. falciparum (22,23).
However, in comparison with previous reports on me-
dicinal plants with antimalaria activity, it is the first re-
port of Crocus sativa to be effective against P. berghei. This 
research was in agreement with another report recently 
published on 2 bioactive compounds isolated from Crocus 
sativa including crocin and safranal and their semi-syn-
thetic derivatives with potent antimalarial activity in vitro 
against P. falciparum chloroquine sensitive strain with IC50 
less than 20 μg/mL (9). 
Ethyl acetate fraction of Crocus sativus stigma in combina-
tion with chloroquine exhibited a synergic pattern against 
chloroquine sensitive P. berghei. In comparison with other 
antimalarial plants, Otostegia persica combinational ther-
apy with chloroquine revealed potentiating against the 
chloroquine sensitive and chloroquine resistant P. berghei 
strains (24). Artemisinin from Artemisia anova and me-
floquine combination treatment has showed also marked 
synergism against P. berghei (25). But, Artemisia aucheri, 
an effective antimalarial plant, in combination with chlo-
roquine has shown an antagonistic pattern (26). 
The mechanism of action of saffron and its main bioac-
tives crocin with carotenoid structure and safranal as an 
unsaturated monoterpenoid against malaria is not clear. 
In a cross-sectional study on malaria status between plas-
ma carotenoids with structures very similar to crucin and 
indicators of disease severity like parasitemia, and antioxi-
dant status with malaria, carotenoid concentrations were 
lower in the patients than in the control subjects (27). This 
study suggested that subjects with acute malaria have sup-
pressed plasma concentrations of antioxidants, and that 
higher plasma carotenoids are associated with more and 
rapid clearance of malaria parasitemia (28,29). There are 
some reports also on immune modulation properties of 
Crocus sativus stigma (30). So, saffron as a rich source of 
crucin with carotenoid structure might act as a biological 
antioxidant supplement useful for reducing the parasit-
emia through alteration of oxidative stress and immune 
modulation especially in combination with malaria stan-
dard drugs. This study showed for the first time that saf-
fron and its fractions has antimalarial activity as well as 
combination of its ethyl acetate fraction with chloroquine, 
which has a synergistic effect on chloroquine sensitive P. 
berghei. However, the exact mechanism of action of saf-
fron, its fractions and its main bioactive like crocin and 
safranal in reducing blood parasite count is not clear and 
more studies are recommended in this regard.
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